Discover trends, market shifts, and competitive outlooks for the angina pectoris drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Angina Pectoris Drugs Market Through 2034?

In the last few years, the market size for angina pectoris medication has seen robust growth. The market, valued at $12.32 billion in 2024, is projected to reach $12.94 billion in 2025, with a compounded annual growth rate (CAGR) of 5.1%. This growth during the historical period can be linked to various factors such as the high occurrence of cardiovascular diseases, an ageing population, lifestyle factors, an increase in hypertension rates, and the prevalence of diabetes.

The market size of drugs for angina pectoris is predicted to experience robust expansion in the upcoming years, reaching a size of “$16.55 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%. The growth during the forecasted period can be ascribed to increasing global obesity levels, advancements in the field of precision medicine, dedication towards preventative cardiology, initiatives for patient education, and research into new therapeutic targets. Key trends for the forecast period encompass telemedicine for distant monitoring, real-world evidence and outcomes-based studies, education focused on patient-centric medication, strategic alliances to secure market access, regulatory improvements, and faster approvals.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10797&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Angina Pectoris Drugs Market?

The rise in cardiovascular disease occurrence is forecasted to fuel the expansion of the angina pectoris drug market. This umbrella term refers to a variety of disorders affecting the heart and blood vessels, such as coronary artery disease, high blood pressure, heart failure, and stroke. The escalating occurrence of these diseases is linked to multiple factors, such as an increase in an aging population, unhealthy lifestyles, and widespread obesity. Angina pectoris drugs, including nitrates, beta-blockers, and calcium channel blockers, efficiently alleviate chest discomfort and pain resulting from inadequate blood supply to the heart, thereby improving the overall well-being of patients. For instance, according to data released by the British Heart Foundation, a UK-based cardiovascular research charity, in September 2024, approximately 7.6 million people in the UK suffer from heart and circulatory diseases, including an estimated 4 million men and 3.6 million women. These diseases account for about 27% of all deaths in the UK, amounting to over 170,000 deaths per annum, or nearly 480 fatalities each day, which means one death approximately every three minutes. Consequently, the rising occurrence of cardiovascular diseases is facilitating the growth of the angina pectoris drug market.

Which Key Market Segments Comprise the Angina Pectoris Drugs Market and Drive Its Revenue Growth?

The angina pectoris drugs market covered in this report is segmented –

1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins, Antihypertensive Agents, Other Drugs

2) By Indication: Stable Angina, Unstable Angina, Prinzmetal’s Angina

3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Nitrates: Short-Acting Nitrates, Long-Acting Nitrates

2) By Antiplatelet Agents: Aspirin, Clopidogrel

3) By Beta-Adrenergic Blocking Agents: Non-Selective Beta Blockers, Selective Beta Blockers

4) By Calcium Channel Blockers: Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers

5) By Anti-Ischemic Agents: Ranolazine, Ivabradine

6) By Statins: Atorvastatin, Rosuvastatin

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10797&type=smp

Which Areas Are Leading Regions in the Angina Pectoris Drugs Market Expansion Across the Globe?

North America was the largest region in the angina pectoris drugs market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina pectoris drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theAngina Pectoris Drugs Market Over the Coming Years?

In the angina pectoris drugs market, the prominent trend is product innovation. To uphold their market dominance, key businesses in this industry are embracing new technologies. For example, in March 2023, Labetalol Hydrochloride Injection, USP, loaded in a prefilled syringe, was introduced by Hikma Pharmaceuticals PLC, a British pharmaceutical firm. This product has been approved by the United States’ Food and Drug Administration. The 10 mg/2 mL PFS is employed in medical facilities to manage severe hypertension and reduce blood pressure.

View the full report here:

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

How Is the Angina Pectoris Drugs Market Conceptually Defined?

Angina pectoris drugs are medications used to treat angina pectoris, a medical illness that causes chest pain or discomfort when a portion of the heart does not receive enough blood and oxygen. Angina pectoris drugs treat chest pain or discomfort due to coronary heart disease.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10797

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model